SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001010412-02-000042
Filing Date
2002-03-25
Accepted
2002-03-25 00:00:00
Documents
11
Period of Report
2002-03-11
Items
Item 5: Other events
Item 7: Financial statements and exhibits
Item 9: Regulation FD Disclosure

Document Format Files

Seq Description Document Type Size
1 8-K CURRENT REPORT DATED MARCH 11, 2002 k.txt 8-K 12359
3 EXCLUSIVE LICENSE AGREEMENT ex-10.txt EX-10 34592
4 SUBSCRIPTION AGREEMENT ex10-2.txt EX-10 166710
5 FUNDS ESCROW AGREEMENT ex10-3.txt EX-10 21754
6 ENGAGEMENT LETTER ex10-4.txt EX-10 4703
7 WARRANT OF RICHARD H. WALKER ex99-1.txt EX-99 28616
8 WARRANT OF MARK BERGENDAHL ex99-2.txt EX-99 28622
9 WARRANT OF BRADLEY J. WILHITE ex99-3.txt EX-99 28626
10 WARRANT OF LEONARD W. BURNINGHAM, ESQ. ex99-4.txt EX-99 26513
11 PRESS RELEASE DATED FEBRUARY 21, 2002 ex99-5.txt EX-99 3815
12 MINUTES OF SPECIAL MEETING OF THE BOARD OF DIRECTORS ON MARCH 11, 2002 ex99-6.txt EX-99 12597
  Complete submission text file 0001010412-02-000042.txt   371781
Mailing Address 101 EAST GREEN ST STE 11 PASADENA CA 91105
Business Address 101 EAST GREEN ST #11 PASADENA CA 91105 8184050079
SANGUINE CORP (Filer) CIK: 0000926287 (see all company filings)

IRS No.: 954347608 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24480 | Film No.: 02584274
SIC: 2835 In Vitro & In Vivo Diagnostic Substances